Inulin Constipation Randomized Trial: What the Evidence Says

Quick Answer

Inulin Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Alterations in gut microbiota composition have been associated with hard stools and slow intestinal transit times. [Puhlmann Marie-Luise (2025); evidence level 2]
• Notably, individuals diagnosed with functional constipation according to the Rome III criteria, were shown to have reduced relative abundances of butyrate-producing taxa in their fecal samples compared to healthy controls. [Puhlmann Marie-Luise (2025); evidence level 2]
• In particular, it may be effective in the management of conditions such as hypertension, diabetes, and liver disease, alongside other potential health benefits, such as its ability to support gastrointestinal health, cardiovascular risk reduction, and metabolic control. [Sanlier Nevin (2026); evidence level 4]
• Studies also emphasize its various metabolic and hepatoprotective effects, including the modulation of bile acid metabolism and the activation of pathways associated with the farnesoid X receptor. [Sanlier Nevin (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For inulin constipation randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Puhlmann Marie-Luise (2025). Inulin-induced improvements on bowel habit and gut microbiota in adults with functional constipation: findings of a randomized, double-blind, placebo-controlled study. DOI: 10.1186/s12876-025-04409-6. PMCID: PMC12613575. PMID: 41233756. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12613575/
• Sanlier Nevin (2026). From Husks and Seeds to Health: an Inevitable Outcome Rather than a Fluke. DOI: 10.1007/s13668-025-00722-4. PMCID: PMC12935724. PMID: 41741921. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12935724/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.